Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Smith

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD StudyFredrik Jernerén, Tommy Cederholm, Helga Refsum, et al.
Neurochemistry International|March 23, 2011
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's diseaseNur-Ezan Mohamed, Yi Zhao, Jasinda H Lee, et al.
JAMA Psychiatry|April 28, 2016
Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults: A Longitudinal Population-Based StudyBabak Hooshmand, Francesca Mangialasche, Grégoria Kalpouzos, et al.
Brain, Behavior, and Immunity|January 25, 2019
The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health StudyStein-Erik Hafstad Solvang, Jan Erik Nordrehaug, Grethe S Tell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2005
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variationC Holmes, C Ballard, D Lehmann, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2014
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohortJeffrey L Seeburger, Daniel J Holder, Marc Combrinck, et al.
Journal of Alzheimer'S Disease : JAD|November 3, 2011
Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluidBaharak Vafadar-Isfahani, Graham Ball, Clare Coveney, et al.
Molecular Psychiatry|May 10, 2022
Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participantsYue-Ting Deng, Yu-Zhu Li, Shu-Yi Huang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?Ruth Peters, Hiroko H Dodge, Sarah James, et al.
The British Journal of Nutrition|November 16, 2013
Interactions between plasma concentrations of folate and markers of vitamin B(12) status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health StudyEsmée L Doets, Per M Ueland, Grethe S Tell, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD StudyFredrik Jernerén, Tommy Cederholm, Helga Refsum, et al.
Neurochemistry International|March 23, 2011
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's diseaseNur-Ezan Mohamed, Yi Zhao, Jasinda H Lee, et al.
JAMA Psychiatry|April 28, 2016
Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults: A Longitudinal Population-Based StudyBabak Hooshmand, Francesca Mangialasche, Grégoria Kalpouzos, et al.
Brain, Behavior, and Immunity|January 25, 2019
The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health StudyStein-Erik Hafstad Solvang, Jan Erik Nordrehaug, Grethe S Tell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2005
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variationC Holmes, C Ballard, D Lehmann, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2014
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohortJeffrey L Seeburger, Daniel J Holder, Marc Combrinck, et al.
Journal of Alzheimer'S Disease : JAD|November 3, 2011
Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluidBaharak Vafadar-Isfahani, Graham Ball, Clare Coveney, et al.
Molecular Psychiatry|May 10, 2022
Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participantsYue-Ting Deng, Yu-Zhu Li, Shu-Yi Huang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?Ruth Peters, Hiroko H Dodge, Sarah James, et al.
The British Journal of Nutrition|November 16, 2013
Interactions between plasma concentrations of folate and markers of vitamin B(12) status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health StudyEsmée L Doets, Per M Ueland, Grethe S Tell, et al.
Pageof 16